Regionalization of percutaneous transluminal coronary angioplasty and implications for patient travel distance.

[1]  J. Birkmeyer,et al.  Regionalization of high-risk surgery and implications for patient travel times. , 2003, JAMA.

[2]  David O. Williams,et al.  ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary , 2001 .

[3]  K A Eagle,et al.  ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coro , 2001, Journal of the American College of Cardiology.

[4]  T. Ryan,et al.  Relation between operator and hospital volume and outcomes following percutaneous coronary interventions in the era of the coronary stent. , 2000, JAMA.

[5]  D. Brown,et al.  Practice of coronary angioplasty in California in 1995 : comparison to 1989 and impact of coronary stenting. , 1999, Circulation.

[6]  J. Gurwitz,et al.  Impact of time to treatment with tissue plasminogen activator on morbidity and mortality following acute myocardial infarction (The second National Registry of Myocardial Infarction). , 1998, The American journal of cardiology.

[7]  E. DeLong,et al.  Relationship between physician and hospital coronary angioplasty volume and outcome in elderly patients. , 1997, Circulation.

[8]  S. Ellis,et al.  Relation of operator volume and experience to procedural outcome of percutaneous coronary revascularization at hospitals with high interventional volumes. , 1997, Circulation.

[9]  E L Hannan,et al.  Coronary angioplasty volume-outcome relationships for hospitals and cardiologists. , 1997, JAMA.

[10]  C. Naylor,et al.  Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction. Canadian GUSTO Investigators. Global Utilization of Streptokinase and + PA for Occluded Coronary Arteries. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[11]  K. Schulman,et al.  Quality assessment in contracting for tertiary care services by HMOs: a case study of three markets. , 1997, The Joint Commission journal on quality improvement.

[12]  R. Brook,et al.  Regionalization of cardiac surgery in the United States and Canada. Geographic access, choice, and outcomes. , 1995, JAMA.

[13]  S. Kimmel,et al.  The relationship between coronary angioplasty procedure volume and major complications. , 1995, JAMA.

[14]  D. Pryor,et al.  The relation between the volume of coronary angioplasty procedures at hospitals treating Medicare beneficiaries and short-term mortality. , 1994, The New England journal of medicine.

[15]  L. Iezzoni.  Risk Adjustment for Measuring Healthcare Outcomes , 1994 .

[16]  H. Luft,et al.  Coronary Angioplasty Statewide Experience in California , 1993, Circulation.

[17]  C. Tilquin,et al.  Risk Adjustment in Outcome Assessment: the Charlson Comorbidity Index , 1993, Methods of Information in Medicine.

[18]  T. Ryan.  Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). , 1988, Journal of the American College of Cardiology.

[19]  K. Powell,et al.  Can regionalization decrease the number of deaths for children who undergo cardiac surgery? A theoretical analysis. , 2002, Pediatrics.

[20]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.